PFE vs XXII · P/E 20, rev $15.03B vs rev $7.0M
Pfizer Inc (PFE) versus 22nd Century Group Inc (XXII) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
22nd Century Group Inc (XXII) is a tobacco company listed on NASDAQ.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported XXII revenue for 2026-06-30 was $7.0M. Net income was -$6.6M. Revenue was up 69.8% from 2026-03-31 to 2026-06-30. XXII currently screens at market cap $1.9M.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. XXII currently screens at market cap $1.9M.
Not investment advice. Open the PFE and XXII stock pages for the full models.
Not investment advice.